| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084251902 |
| P356 | DOI | 10.1186/S13045-017-0445-8 |
| P932 | PMC publication ID | 5372308 |
| P698 | PubMed publication ID | 28356122 |
| P50 | author | Min Sun | Q91940108 |
| P2093 | author name string | Qing Liu | |
| Chen Wei | |||
| Liang Zheng | |||
| Yuanyuan Chen | |||
| Min Sun | |||
| Fangfang Chen | |||
| Shuyi Wang | |||
| Chunxiao Zhang | |||
| Haibin Song | |||
| Chaogang Yang | |||
| Dongdong Shi | |||
| Zhenxian Xiang | |||
| P2860 | cites work | miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer | Q45119395 |
| Hippo/YAP, β-catenin, and the cancer cell: a "ménage à trois" in hepatoblastoma | Q46397118 | ||
| A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer | Q46799300 | ||
| MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. | Q51116914 | ||
| MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. | Q52906148 | ||
| Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner. | Q55042519 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| The Hippo pathway in colorectal cancer | Q28082847 | ||
| Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer | Q28086905 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Key issues in conducting a meta-analysis of gene expression microarray datasets | Q33366123 | ||
| BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource | Q33414654 | ||
| Biomarker detection in the integration of multiple multi-class genomic studies | Q33627563 | ||
| Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding | Q33764157 | ||
| microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway | Q33792672 | ||
| Expression of hippo pathway in colorectal cancer | Q33796051 | ||
| miRBase Tracker: keeping track of microRNA annotation changes. | Q34080546 | ||
| A Protective Role by Interleukin-17F in Colon Tumorigenesis | Q34235509 | ||
| Colorectal cancer statistics, 2014. | Q34660408 | ||
| Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells | Q34770004 | ||
| Diagnostic and prognostic microRNAs in stage II colon cancer. | Q34803800 | ||
| microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma. | Q35684366 | ||
| Estrogen regulates Hippo signaling via GPER in breast cancer | Q35720044 | ||
| Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability | Q35740352 | ||
| Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers. | Q35835222 | ||
| Comprehensive literature review and statistical considerations for microarray meta-analysis | Q35955982 | ||
| The emerging roles of YAP and TAZ in cancer | Q36035567 | ||
| miR-195 is a key regulator of Raf1 in thyroid cancer | Q36208479 | ||
| miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer | Q36244787 | ||
| The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression | Q36278724 | ||
| An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection | Q36294024 | ||
| Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. | Q36297343 | ||
| Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. | Q36413124 | ||
| MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. | Q36433424 | ||
| Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells | Q36544177 | ||
| Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation | Q36545805 | ||
| Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile | Q36555317 | ||
| MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression | Q36615420 | ||
| Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance | Q36923438 | ||
| Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers | Q37113145 | ||
| miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer. | Q37295543 | ||
| MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer | Q37588827 | ||
| Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism | Q37591581 | ||
| Integration of intercellular signaling through the Hippo pathway | Q38007284 | ||
| MicroRNA-binding site polymorphisms in hematological malignancies. | Q38271148 | ||
| MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas | Q38301716 | ||
| Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway | Q38514410 | ||
| Molecular biomarkers in gastric cancer. | Q38519985 | ||
| YAP and TAZ Take Center Stage in Cancer | Q38606718 | ||
| Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231. | Q38819255 | ||
| MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells | Q38838196 | ||
| EMT: 2016. | Q38883448 | ||
| The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer | Q38903548 | ||
| Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer | Q39030071 | ||
| Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer | Q39101905 | ||
| Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model | Q45039242 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| microRNA | Q310899 | ||
| P304 | page(s) | 79 | |
| P577 | publication date | 2017-03-29 | |
| P1433 | published in | Journal of Hematology & Oncology | Q15724593 |
| P1476 | title | Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer | |
| P478 | volume | 10 |
| Q59794098 | CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells |
| Q58736691 | Circular RNA: new star, new hope in cancer |
| Q90153969 | Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways |
| Q59806405 | Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer |
| Q90363489 | Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors |
| Q58780656 | Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis |
| Q58122535 | Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis |
| Q94463937 | Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics |
| Q90675894 | Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis |
| Q89147806 | Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNA‑ceRNA interaction network in colorectal cancer |
| Q91712290 | Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer |
| Q92361660 | Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer |
| Q90390289 | Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis |
| Q97067035 | Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies |
| Q92366663 | Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling |
| Q54122877 | MiR-126 functions as a tumor suppressor by targeting SRPK1 in human gastric cancer |
| Q47134775 | MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP. |
| Q89883711 | MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1 |
| Q55027570 | MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells. |
| Q58547821 | MicroRNA-195: a review of its role in cancers |
| Q64235853 | MicroRNA-related transcription factor regulatory networks in human colorectal cancer |
| Q55509409 | MicroRNA‑195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer. |
| Q61798124 | Msx1 loss suppresses formation of the ectopic crypts developed in the Apc-deficient small intestinal epithelium |
| Q49571165 | Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway |
| Q55307845 | Prognostic value of microRNAs in colorectal cancer: a meta-analysis. |
| Q103759593 | Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective |
| Q60917456 | The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression |
| Q92886973 | Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells |
| Q64228191 | Upregulation of STC2 in colorectal cancer and its clinicopathological significance |
| Q90370797 | YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer |
| Q89924216 | m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC |
| Q42368955 | miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma. |
| Q61797342 | miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC |
| Q92617046 | miR-195 inhibits esophageal cancer cell proliferation and promotes apoptosis by downregulating YAP1 |
| Q64101718 | miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization |
Search more.